Sample analysis method and sample analysis apparatus

Through capillary electrophoresis and time differential waveform analysis, combined with relevant parameters of known components to correct the detection time, the peak overlap problem in hemoglobin analysis was solved, and the accurate identification of Hb species was achieved.

CN119178743APending Publication Date: 2024-12-24ARKRAY INC
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202410712700.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-06-21
Filing Date
2024-06-04
Publication Date
2024-12-24

AI Technical Summary

Technical Problem

In the prior art, hemoglobin analysis method is prone to peak overlap when the Hb concentration in the body to be tested changes, making it difficult to determine the Hb species.

Method used

Capillary electrophoresis is used to separate multiple components in the sample, obtain the electrophoresis diagram and determine the detection time and concentration of each peak through the time differential waveform. The detection time is corrected using the relevant parameters of known components, and then the components contained in the sample are determined. .

Benefits of technology

It is possible to accurately determine the Hb species in the sample without relying on the concentration of components, avoiding analysis difficulties caused by peak overlap.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119178743A_ABST
    Figure CN119178743A_ABST
Patent Text Reader

Abstract

Provided are a sample analysis method and a sample analysis device with which it is possible to identify a component contained in a sample regardless of the concentration of the component contained in the sample. A sample analysis method includes: a step for separating a plurality of components contained in a sample by capillary electrophoresis; a step for obtaining an electrophoretogram of the sample; a step for acquiring the detection time for each peak and the concentration corresponding to each peak on the basis of the electrophoretogram; and a step for specifying the component contained in the sample using a parameter indicating the correlation between the detection time and the concentration calculated using the known component for the acquired detection time and the acquired concentration.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a sample analysis method and a sample analysis device. Background Art

[0002] In clinical examinations, the analysis of hemoglobin (hereinafter also referred to as "Hb") is a daily routine. The type of Hb that is the subject of analysis varies depending on the purpose of the examination. HbA1c is known as an analysis object for the diagnosis and understanding of the condition of diabetes. As an analysis object for the diagnosis of abnormal Hb disease, mutant Hb represented by HbS (sickle cell Hb), HbC, HbD and HbE are used. In addition, as an analysis object for the diagnosis of β-thalassemia, HbA2 and HbF (fetal Hb) are widely used.

[0003] Hb is analyzed by high performance liquid chromatography (HPLC) such as ion exchange chromatography, capillary electrophoresis (CE), or the like.

[0004] Patent Document 1 describes a method for analyzing HbA2 by anion exchange electrokinetic chromatography using a solution containing a cationic polymer as a pseudo stationary phase.

[0005] Patent Documents 2 and 3 describe analytical methods for determining components such as HbA1c using the interface arrival time point based on ion exchange electrokinetic chromatography.

[0006] Prior Art Literature

[0007] Patent Literature

[0008] Patent Document 1: Japanese Patent Application Publication No. 2016-136135;

[0009] Patent document 2: Japanese Patent No. 6846324;

[0010] Patent document 3: Japanese Patent No. 6871129. Summary of the invention

[0011] When the method described in Patent Document 1 is used, the miniaturization of the device and the shortening of the measurement time can be achieved. In addition, by combining with the method described in Patent Document 2 or Patent Document 3, the Hb type of each peak can be determined based on the relative detection time using a simple device. However, in these methods, if the Hb concentration in the sample changes, there is a situation where the peaks overlap. If the peaks overlap, it is difficult to determine the Hb type.

[0012] An embodiment of the present disclosure is to provide a sample analysis method and a sample analysis device capable of determining components contained in a sample regardless of the concentration of the components contained in the sample.

[0013] The present disclosure includes the following aspects.

[0014] <1> A sample analysis method, comprising:

[0015] A process of separating multiple components contained in a sample by capillary electrophoresis;

[0016] A step of obtaining an electrophoretic pattern of the sample;

[0017] A step of obtaining the detection time of each peak and the concentration corresponding to each peak according to the electrophoresis diagram; and

[0018] A step of determining a component contained in the sample using a parameter for the acquired detection time and the acquired concentration, wherein the parameter represents a correlation between the detection time and the concentration calculated using known components.

[0019] <2> according to <1> The sample analysis method, wherein:

[0020] The process of obtaining the electrophoresis pattern of the sample comprises:

[0021] A step of optically measuring the sample to obtain absorbance;

[0022] A step of obtaining the absorbance as an original waveform plotted on a two-dimensional plane along a time axis; and

[0023] a step of acquiring a time-differentiated waveform, wherein the time-differentiated waveform is a waveform obtained by differentiating the original waveform along the time axis,

[0024] According to the electrophoresis diagram, the process of obtaining the detection time of each peak and the concentration corresponding to each peak includes:

[0025] Acquire the detection time of each peak in the time differential waveform, and acquire the absorbance corresponding to the acquired detection time of each peak,

[0026] The process of determining the components contained in the sample comprises:

[0027] A step of determining a component contained in the sample using a parameter for the acquired detection time and the acquired absorbance, wherein the parameter represents a correlation between the detection time and the absorbance calculated using known components.

[0028] <3> according to <1> or <2> The sample analysis method, wherein:

[0029] The parameter indicating the correlation between the detection time and the concentration is a parameter obtained by plotting the detection time and the absorbance on a two-dimensional plane using a known component.

[0030] <4> according to <3> The sample analysis method, wherein:

[0031] The parameter representing the correlation between the detection time and the concentration is data of the slope of an approximate straight line for each component obtained by plotting the detection time and absorbance on a two-dimensional plane using known components.

[0032] The process of determining the components contained in the sample comprises:

[0033] The step of correcting the acquired detection time using the slope data to calculate the corrected detection time; and

[0034] A step of specifying a component contained in the sample based on the corrected detection time.

[0035] <5> according to <3> The sample analysis method, wherein:

[0036] The parameter representing the correlation between the detection time and the concentration is data of a boundary line separated by component obtained by plotting the detection time and absorbance on a two-dimensional plane using known components.

[0037] The process of determining the components contained in the sample comprises:

[0038] using the data of the boundary line, determining, in each area separated by the boundary line, an area to which the acquired detection time and the acquired absorbance belong; and

[0039] A step of determining components contained in the sample based on the determined region.

[0040] <6> according to <1> ~ <5> The sample analysis method according to any one of the preceding claims, wherein the component is hemoglobin.

[0041] <7> A sample analysis device, comprising:

[0042] A method of separating multiple components contained in a sample by capillary electrophoresis;

[0043] means for obtaining an electrophoretic pattern of the sample;

[0044] According to the electrophoresis diagram, a means for obtaining the detection time of each peak and the concentration corresponding to each peak; and

[0045] Means for determining a component contained in the sample using a parameter for the acquired detection time and the acquired concentration, wherein the parameter represents a correlation between the detection time and the concentration calculated using known components.

[0046] According to one embodiment of the present disclosure, there is provided a sample analysis method and a sample analysis device capable of identifying components contained in a sample regardless of the concentration of the components contained in the sample. BRIEF DESCRIPTION OF THE DRAWINGS

[0047] Figure 1 A is a top view showing one embodiment of a capillary electrophoresis chip; Figure 1 B is Figure 1 A is a cross-sectional view of the electrophoresis chip.

[0048] Figure 2 is a diagram showing an example of an original waveform.

[0049] Figure 3 It means relative to Figure 2 A plot of the time-differentiated waveform of the original waveform.

[0050] Figure 4 This is a graph in which the horizontal axis represents the relative detection time PkTimeRt and the vertical axis represents the absorbance TlAbs.

[0051] Figure 5 This is a diagram showing an example of the relationship between the type of Hb and the corrected detection time.

[0052] Figure 6 This is a graph in which the horizontal axis represents the relative detection time PkTimeRt and the vertical axis represents the absorbance TlAbs.

[0053] Figure 7 1 is a system schematic diagram showing a sample analysis system that can be used to execute the sample analysis method of the present embodiment.

[0054] Figure 8 Yes means Figure 7 A top view of the analysis chip used in the sample analysis system.

[0055] Fig. 9 It is along Figure 8 Cross-sectional view along line III-III.

[0056] Fig.10 This is a block diagram showing the hardware configuration of the control unit.

[0057] Fig.11 It is a graph showing the relationship between Hb types and relative detection time. DETAILED DESCRIPTION

[0058] Hereinafter, an embodiment as an example of the present invention will be described. These descriptions and examples illustrate the embodiment and do not limit the scope of the invention.

[0059] In the numerical range recorded in stages in the present disclosure, the upper limit or lower limit recorded in a numerical range can also be replaced by the upper limit or lower limit of the numerical range recorded in other stages. In addition, in the numerical range recorded in the present disclosure, the upper limit or lower limit of its numerical range can also be replaced by the value shown in the embodiment.

[0060] When referring to the amount of each component in a composition, if there are a plurality of substances corresponding to each component in the composition, unless otherwise specified, it refers to the total amount of the plurality of substances present in the composition.

[0061] In the present disclosure, the term "process" refers not only to an independent process but also to a process that cannot be clearly distinguished from other processes as long as the intended purpose of the process is achieved.

[0062] In the present disclosure, a combination of two or more preferred aspects is a more preferred aspect.

[0063] In the present disclosure, when an embodiment is described with reference to the drawings, the structure of the embodiment is not limited to the structure shown in the drawings. In addition, the sizes of components in each figure are conceptual, and the relative relationship between the sizes of the components is not limited to this.

[0064] [Sample analysis method]

[0065] The sample analysis method involved in the present disclosure includes: a process of separating multiple components contained in a sample by capillary electrophoresis (hereinafter also referred to as the "separation process"); a process of obtaining an electrophoretogram of the sample (hereinafter also referred to as the "electrophoretogram acquisition process"); a process of obtaining the detection time of each peak and the concentration corresponding to each peak based on the electrophoretogram (hereinafter also referred to as the "detection time / concentration acquisition process"); and a process of determining the components contained in the sample using parameters for the obtained detection time and the obtained concentration, wherein the parameters represent the correlation between the detection time and the concentration calculated using known components (hereinafter also referred to as the "component determination process").

[0066] According to the sample analysis method according to the present disclosure, it is possible to identify components contained in a sample regardless of the concentration of the components contained in the sample.

[0067] For example, the genotype of a person with variant hemoglobin is a heterozygote of HbA / HbV (HbV is a variant hemoglobin other than HbA) or a homozygote of HbV / HbV. Compared with the blood of a heterozygote, the blood of a homozygote tends to have a higher concentration of Hb (HbV) and an earlier peak. Due to the earlier peak, there are cases where multiple peaks overlap.

[0068] Conventionally, in identifying the type of Hb contained in a sample, if peaks overlap, it may be difficult to identify the type of Hb.

[0069] The inventors have found that there is a correlation between the detection time of each peak that can be obtained from the electrophoresis diagram and the concentration corresponding to each peak. Furthermore, the inventors have found that the components contained in the sample can be accurately determined regardless of the concentration of each component by using a parameter that represents the correlation between the detection time and the concentration calculated using known components.

[0070] <Separation process>

[0071] The sample analysis method according to the present disclosure includes a step of separating a plurality of components contained in a sample by capillary electrophoresis.

[0072] The sample may be in any form, such as liquid, solid, or gas, as long as it contains components that can be analyzed by capillary electrophoresis and can be dissolved in such a solvent.

[0073] As the components contained in the sample that are the subject of analysis, hemoglobin (Hb), albumin (Alb), globulin (α1, α2, β, γ globulin), fibrinogen, etc. can be cited. As the above-mentioned hemoglobin, for example, HbA, HbA2, HbF (fetal hemoglobin), variant hemoglobin (HbC, HbD, HbE, HbG, HbS, etc.) and other types of hemoglobin can be cited. The whole blood of healthy people and mutant hemoglobin holders contains a trace amount of HbA2. These components are suitable for analysis based on capillary electrophoresis because the variation of amino acids as constituent elements is easily reflected by protein molecules.

[0074] Furthermore, depending on the components to be analyzed, the sample may be pre-treated with an appropriate reagent, or a preliminary separation treatment may be performed by another method (eg, chromatography).

[0075] The separation of Hb is usually carried out in a moving medium, which can be an alkaline solution or an acidic solution, but is preferably an alkaline solution.

[0076] The sample contains, for example, HbA2, HbE, HbA, HbF, HbC, HbD, HbG, HbS, etc.

[0077] Separation of Hb in a sample by capillary electrophoresis in an alkaline solution can be performed using a device equipped with a capillary channel.

[0078] Specifically, the method can be performed by introducing a sample into a capillary channel filled with an alkaline solution, and then applying a voltage to the entire or a part of the capillary channel after the sample is introduced. By applying the voltage, Hb in the sample can be electrophoresed and separated.

[0079] The voltage can be applied to the capillary flow channel by bringing a negative electrode into contact with the sample introduction side of the capillary flow channel and bringing a positive electrode into contact with the alkaline solution supply side.

[0080] The cross-sectional shape of the capillary flow channel is not particularly limited, and may be circular, rectangular, or other shapes.

[0081] In the case of a rectangular shape, the channel height and channel width of the capillary channel are preferably 1 μm to 1000 μm, more preferably 10 μm to 200 μm, and further preferably 25 μm to 100 μm. In the case of a circular shape, the inner diameter of the capillary channel is preferably 10 μm or more or 25 μm or more, and preferably 100 μm or less or 75 μm or less.

[0082] The flow path length of the capillary flow path is preferably 5 mm to 150 mm, more preferably 10 mm to 150 mm, and even more preferably 20 mm to 60 mm.

[0083] The material of the capillary channel is not particularly limited, and examples thereof include glass, fused silica, plastics, etc. Examples of plastics include polymethyl methacrylate (PMMA), polycarbonate, polystyrene, polytetrafluoroethylene (PTFE), polyetheretherketone (PEEK), and the like.

[0084] In the separation step, a capillary electrophoresis chip in which the capillary flow path is microchipped may be used. Figure 1 A and Figure 1 The capillary electrophoresis chip shown in B and the capillary electrophoresis chip described later Figure 8 and Fig. 9 The analysis chip shown is an example of a chip used in capillary electrophoresis.

[0085] The capillary electrophoresis chip may include a sample holding tank, a moving liquid holding tank, and a capillary flow path, and the sample holding tank and the moving liquid holding tank are connected to each other through the capillary flow path.

[0086] The size of the capillary electrophoresis chip is not particularly limited, and is preferably adjusted appropriately. The size of the capillary electrophoresis chip is, for example, 10 mm to 200 mm in length, 1 mm to 60 mm in width, and 0.3 mm to 5 mm in thickness.

[0087] The volumes of the sample holding tank and the moving liquid holding tank are appropriately determined according to the inner diameter and length of the capillary flow path, and are preferably 1 mm 3 ~1000mm 3 , more preferably 5mm 3 ~100mm 3 .

[0088] The amount of the sample filled in the sample holding tank is not particularly limited, and can be 1 μL to 30 μL.

[0089] The amount of the alkaline solution filled in the electrophoresis liquid holding tank is not particularly limited, and can be 1 μL to 30 μL.

[0090] The voltage applied to both ends of the capillary flow channel is preferably 500V to 20,000V, more preferably 500V to 10,000V, and even more preferably 500V to 5,000V.

[0091] A liquid flow from the negative electrode side to the positive electrode side may also be generated in the capillary flow channel. Examples of the liquid flow include electroosmotic flow and the like.

[0092] The inner wall of the capillary channel is preferably covered with a cationic substance or an anionic substance.

[0093] By coating the inner wall of the capillary flow channel with a cationic substance, the inner wall of the capillary flow channel can be positively charged, thereby making it easy to generate an electroosmotic flow from the negative electrode side to the positive electrode side in the capillary flow channel.

[0094] When the inner wall of the capillary flow path is covered with anionic substances, the inner wall of the capillary flow path is negatively charged, but the cationic polymer contained in the alkaline solution is combined with the negatively charged inner wall of the capillary flow path. As a result, the inner wall of the capillary flow path is positively charged, and similarly to the above, an electroosmotic flow from the negative electrode side to the positive electrode side can be easily generated in the capillary flow path.

[0095] The cationic substance is not particularly limited, and a silane coupling agent having a cationic functional group can be used. From the viewpoint of improving separation accuracy, the cationic substance is preferably a polymer having a quaternary ammonium salt group, and more preferably polydiallyldimethylammonium chloride.

[0096] The anionic substance is not particularly limited, and polysaccharides having anionic groups, silane coupling agents having anionic functional groups, and the like can be used.

[0097] Examples of the polysaccharide having an anionic group include sulfated polysaccharides, carboxylated polysaccharides, sulfonated polysaccharides, and phosphorylated polysaccharides.

[0098] Examples of the sulfated polysaccharides include chondroitin sulfate, heparin, heparan, fucoidan, and salts thereof, etc. Examples of the carboxylated polysaccharides include alginic acid, hyaluronic acid, and salts thereof, etc.

[0099] Figure 1 A and Figure 1 B represents an embodiment of a capillary electrophoresis chip. Figure 1A is a top view showing one embodiment of a capillary electrophoresis chip, Figure 1 B is Figure 1 A is a cross-sectional view of the electrophoresis chip.

[0100] Figure 1 A and Figure 1 The capillary electrophoresis chip shown in FIG. 1B includes a capillary channel 1, a sample holding reservoir 2, and a moving liquid holding reservoir 3. The sample holding reservoir 2 and the moving liquid holding reservoir 3 are connected to each other through the capillary channel 1. A detection unit 4 is formed in the capillary channel 1.

[0101] The sample holding tank 2 and the moving liquid holding tank 3 may each include electrodes (not shown) for applying voltage to both ends of the capillary channel 1. Specifically, the sample holding tank 2 (sample introduction side) may include a negative electrode, and the moving liquid holding tank 3 (alkaline solution supply side) may include a positive electrode.

[0102] The position of the detection unit 4, that is, the length required for separation (the distance from the sample holding tank 2 to the detection unit 4, Figure 1 The x in A can be appropriately determined according to the length of the capillary channel 1 and the like. Figure 1 When (x+y) in A is 10 mm to 150 mm, the distance (x) from the sample holding tank 2 to the detection unit 4 is preferably 5 mm to 140 mm, more preferably 10 mm to 100 mm, and even more preferably 15 mm to 50 mm.

[0103] -Alkaline solution-

[0104] In the present disclosure, "alkaline" means a pH exceeding 7.0. The pH of the alkaline solution is preferably higher than the isoelectric point of Hb, preferably 7.5 to 12.0, more preferably 8.5 to 11.0, and even more preferably 9.5 to 10.5.

[0105] In the present disclosure, the pH of the alkaline solution is the pH of the alkaline solution at 25° C. and is measured using a pH meter 30 minutes after the electrode is immersed. As the pH meter, F-72 manufactured by Horiba, Ltd. or an equivalent device can be used.

[0106] The alkaline solution contains a cationic polymer. The alkaline solution may contain two or more cationic polymers.

[0107] In the present disclosure, "cationic polymer" refers to a polymer having a cationic group.

[0108] In the present disclosure, the "cationic group" includes a cationic group and a group that is ionized to become a cationic group.

[0109] Examples of the cationic group include a primary amino group, a secondary amino group, a tertiary amino group, a quaternary ammonium salt group, and an imino group.

[0110] The cationic polymer is preferably water-soluble. In the present disclosure, "water-soluble" means that the target substance dissolves in water at 25°C by 1% by mass or more.

[0111] Examples of cationic polymers having primary to tertiary amino groups or cationic groups that can be ionized to become primary to tertiary amino groups include polyallylamine, polyvinylamine, polylysine, polyarginine, polyhistidine, polyornithine, polydiallylamine, polymethyldiallylamine, polyethyleneimine, diallylamine-acrylamide polymers, dimethylamine-ammonia-epichlorohydrin polymers, allylamine-diallylamine polymers, etc. The cationic polymers may be in the form of salts, and examples thereof include hydrochlorides, etc.

[0112] Examples of the cationic polymer having an imino group or a cationic group that can be ionized to become an imino group include polyethyleneimine and the like.

[0113] Examples of the cationic polymer having a quaternary ammonium base group or a cationic group that can be ionized to become a quaternary ammonium base group include polyquaternium salts, dimethylamine-ammonia-epichlorohydrin polymers, and dimethylamine-epichlorohydrin polymers.

[0114] In the present disclosure, "polyquaternium salt" refers to a cationic polymer containing a structural unit derived from a monomer having a quaternary ammonium group. Polyquaternium salts can be confirmed by the INCI (International Nomenclature for Cosmetic Ingredients) catalog. As polyquaternium salts, in one or more embodiments, polyquaternium salt-6 (poly (diallyldimethylammonium chloride), polyquaternium salt-7 (copolymer of acrylamide and diallyldimethylammonium chloride), polyquaternium salt-4 (Diallyldimethylammonium chloride-hydroxyethylcellulose copolymer), polyquaternium salt-22 (copolymer of acrylic acid anddiallyldimethylammoniumchloride, copolymer of acrylic acid and diallyldimethylammonium chloride) and other polydiallyldimethylammonium salts, and polyquaternium-2 (poly[bis(2-chloroethyl)ether-alt-1,3-bis[3-(dimethylamino)propyl]urea], poly[bis(2-chloroethyl)ether-alt-1,3-bis[3-(dimethylamino)propyl]urea]) and the like.

[0115] Furthermore, as the cationic polymer, in addition to the above-mentioned ammonium salts, in one or more embodiments, a cationic polymer of an onium salt such as a phosphonium salt, an oxonium salt, a sulfonium salt, a fluoroonium salt, or a chloroonium salt may be used.

[0116] Examples of the cationic polymer having a hydrazide group or a cationic group that can be ionized to become a hydrazide group include amino polyacrylamide and the like.

[0117] From the viewpoint of shortening the separation time, the weight average molecular weight of the cationic polymer is preferably 10,000 to 500,000.

[0118] In the present invention, the weight average molecular weight of the cationic polymer refers to the catalog value. When there is no catalog value for the weight average molecular weight, the weight average molecular weight is the weight average molecular weight in terms of polyethylene glycol measured by gel permeation chromatography (GPC).

[0119] From the viewpoint of shortening the separation time, the content of the cationic polymer relative to the total mass of the alkaline solution is preferably 0.5 to 10 mass %, more preferably 0.75 to 5.0 mass %, and even more preferably 1.0 to 3.0 mass %.

[0120] The cationic polymer may be one synthesized by a conventionally known method or one that is commercially available.

[0121] The alkaline solution may contain water. Examples of the water include distilled water, ion-exchanged water, pure water, and ultrapure water.

[0122] The content of water relative to the total mass of the alkaline solution is not particularly limited, and can be 10% by mass to 99.9% by mass.

[0123] The alkaline solution may contain additives such as a non-surfactant type zwitterionic substance, a pH buffer substance, and a preservative for inhibiting the growth of microorganisms. Examples of the preservative include sodium azide, ethyl paraben, and ProClin (registered trademark).

[0124] - Sample -

[0125] The total amount of Hb content relative to the total mass of the sample is not particularly limited, and can be 0.001 mass % to 100 mass %.

[0126] The form of the sample is not particularly limited, and may be a sample for preparing a sample raw material, or may be the sample raw material itself.

[0127] Examples of the sample raw material include raw materials containing Hb and biological samples.

[0128] Examples of biological samples include blood-derived materials including blood and red blood cell components.

[0129] Examples of the blood include blood collected from a living body, blood of mammals other than humans, and human blood.

[0130] Examples of blood-derived materials containing red blood cell components include materials separated or prepared from blood and containing red blood cell components, such as blood cell fractions from which plasma has been removed, blood cell concentrates, freeze-dried products of blood or blood cells, hemolyzed samples obtained by hemolyzing whole blood, centrifuged blood, naturally sedimented blood, washed blood cells, and the like.

[0131] From the viewpoint of improving separation accuracy, the sample preferably contains an alkaline solution containing a cationic polymer.

[0132] The sample containing the above-mentioned alkaline solution can be obtained by diluting the sample raw material using the above-mentioned alkaline solution. The dilution rate is preferably 1.2 times to 100 times by mass, more preferably 2 times to 60 times, and further preferably 3 times to 50 times. The materials used in the dilution are not particularly limited, and examples thereof include pH adjusters (such as hydrochloric acid, etc.), surfactants (such as EMULGENLS-110 (manufactured by Kao), etc.), preservatives (such as sodium azide, etc.), ionic strength adjusters (such as sodium chloride, etc.), refractive index adjusters (such as sugars such as sucrose), etc.

[0133] In addition, the alkaline solution may be the same as or different from the alkaline solution filled in the capillary channel.

[0134] <Electrophoresis pattern acquisition step>

[0135] The sample analysis method disclosed herein includes a process of obtaining an electrophoresis diagram of the sample. Specifically, the electrophoresis diagram obtaining process preferably includes: a process of optically measuring the sample to obtain absorbance; a process of obtaining the absorbance as an original waveform drawn on a two-dimensional plane along a time axis; and a process of obtaining a time-differentiated waveform, wherein the time-differentiated waveform is a waveform obtained by differentiating the original waveform along the time axis.

[0136] Figure 2 is a diagram showing an example of an original waveform.

[0137] Figure 3 It means relative to Figure 2 A plot of the time-differentiated waveform of the original waveform.

[0138] (Step of optically measuring the sample to obtain absorbance)

[0139] The absorbance is measured, for example, by the following method.

[0140] The sample is continuously introduced into the capillary flow path, and multiple components contained in the sample are separated by applying voltage in the capillary flow path. In the detection unit 4 provided in the middle of the capillary flow path, light with a wavelength of 415 to 420 nm is irradiated, and the absorbance is measured by an absorbance measuring device.

[0141] For example, when the component of the analysis object is Hb, its molecular surface carries a negative charge in an alkaline solution, so by configuring a cathode upstream of the capillary flow path and an anode downstream, the component of the analysis object migrates toward the anode. At this time, the electrophoretic velocity varies according to the charge state of the molecular surface. That is, the stronger the negative charge on the molecular surface, the higher the migration velocity. Therefore, after the sample is introduced into the capillary flow path, the component with a high migration velocity reaches the detection unit faster.

[0142] Moreover, at the moment when the component with a low swimming speed reaches the detection part, the component with a high swimming speed from the sample introduced later also reaches the detection part. That is, in the capillary flow path, if the component with a high swimming speed reaches the detection part first, the component will continue to arrive as long as the sample is continuously introduced into the capillary flow path. In addition, the component with a lower swimming speed arrives at the detection part later, but once it reaches the detection part, the component will continue to arrive at the detection part as long as the sample is continuously introduced into the capillary flow path.

[0143] In other words, the component with a high migration speed arrives at the detection section first, and the components with a lower migration speed arrive cumulatively later. Therefore, the absorbance measured in the detection section increases monotonically and cumulatively with the passage of time.

[0144] (Process of obtaining absorbance as a raw waveform plotted on a two-dimensional plane along the time axis)

[0145] The original waveform is obtained by plotting on a two-dimensional plane with absorbance as one axis (e.g., Y axis) and time as the other axis (e.g., X axis). In addition, absorbance only needs to be obtained as data that can be plotted on a two-dimensional plane, and it is not necessary to actually plot a graph based on such data.

[0146] (Step of obtaining a time-differentiated waveform obtained by differentiating the original waveform along the time axis)

[0147] When observing the above-mentioned original waveform along the time axis, the part with a large gradient comes from the increase in absorbance caused by the first arrival of a certain component at the detection section 4. In addition, the part with a small gradient indicates that the next component has not yet arrived at the detection section 4. That is, the part where the gradient becomes larger in the original waveform indicates that the component in the sample solution has arrived at the detection section 4. The part with a large gradient in such an original waveform is a peak waveform that appears in the waveform obtained by differentiating the original waveform along the time axis (called a "time-differential waveform"). These peak waveforms originate from the various components contained in the sample. In addition, in the time axis, the component corresponding to the peak waveform located further to the left indicates that the swimming speed is higher than the component corresponding to the peak waveform located further to the right.

[0148] <Detection time / concentration acquisition process and component determination process>

[0149] The sample analysis method according to the present disclosure includes the step of acquiring the detection time of each peak and the concentration corresponding to each peak based on the electrophoresis graph.

[0150] In addition, the sample analysis method according to the present disclosure includes: determining a component contained in the sample using a parameter for the acquired detection time and the acquired concentration, wherein the parameter represents a correlation between the detection time and the concentration calculated using known components.

[0151] The detection time / concentration acquisition step preferably includes the step of acquiring the detection time of each peak in the time-differentiated waveform and acquiring the absorbance corresponding to the acquired detection time of each peak.

[0152] The component identification step preferably includes a step of identifying a component contained in the sample using a parameter representing a correlation between the detection time and the absorbance calculated using a known component, with respect to the acquired detection time and the acquired absorbance.

[0153] The parameter indicating the correlation between the detection time and the absorbance calculated using the known components (hereinafter also referred to as “specific parameter”) is preferably set in advance in the sample analyzer before analyzing the sample to be analyzed.

[0154] The specific parameter is preferably a parameter obtained by plotting the detection time and absorbance on a two-dimensional plane using a known component.

[0155] Hereinafter, a specific method of identifying components contained in a sample using specific parameters will be described.

[0156] (Method A)

[0157] In method A, the specific parameter is data of the slope of an approximate straight line by component obtained by plotting detection time and absorbance on a two-dimensional plane using a known component.

[0158] In method A, the step of determining the components contained in the sample includes: the step of correcting the acquired detection time using the slope data to calculate the corrected detection time; and the step of determining the components contained in the sample based on the corrected detection time.

[0159] The specific parameters in method A are calculated, for example, by the following method.

[0160] By capillary electrophoresis, the absorbance is obtained using known Hb species with different concentrations. The original waveform A is obtained by plotting the absorbance on a two-dimensional plane along the time axis, and the waveform obtained by differentiating the original waveform A along the time axis, that is, the time-differentiated waveform A, is obtained. The X-axis is set to time, and the Y-axis is set to the absorbance change.

[0161] Based on the time-differentiated waveform A, the following data is obtained.

[0162] PkTime: The maximum value of the peak is set to PkTop, which refers to the detection time in PkTop.

[0163] ·PkBtTime: The minimum value immediately before PkTop is set as PkBt, which refers to the detection time in PkBt.

[0164] ·PkTlTime: The minimum value immediately after PkTop is set as PkTl, which refers to the detection time in PkTl.

[0165] EOFTime: refers to the earliest detection time among the detection times in PkTop where the absorbance change exceeds 0.2 mAbs / sec.

[0166] ·PkArea: refers to the cumulative value of the absorbance change from PkBtTime to PkTlTime in PkTop.

[0167] Pk%: refers to the proportion (%) of each PkArea in the total PkArea.

[0168] A2Time: refers to the PkTime of HbA2. The PkTime of the peak immediately after the EOFTime and with a Pk% of 1% or more is defined as the A2Time.

[0169] Based on the following formula A, PkTime is converted into the relative detection time PkTimeRt.

[0170] PkTimeRt=(PkTime-EOFTime) / (A2Time-EOFTime)…Formula A

[0171] In the above formula A, A2Time is used to calculate the relative detection time, but the detection time of HbA in the blood or a protein (a protein that absorbs a wavelength of 415 nm and exhibits the same behavior as Hb) added externally to the sample may be used instead of A2Time.

[0172] Next, the absorbance TlAbs corresponding to PkTlTime is obtained according to the original waveform A.

[0173] Alternatively, the absorbance corresponding to PkTime may be acquired instead of the absorbance TlAbs.

[0174] Figure 4 This is a graph in which the horizontal axis represents the relative detection time PkTimeRt and the vertical axis represents the absorbance TlAbs.

[0175] like Figure 4 As shown in FIG. 1 , approximate straight lines are drawn for each Hb type, and the slopes of the approximate straight lines are calculated for each type. Then, the average value of the slopes of the approximate straight lines is calculated.

[0176] Based on the following formula B, the corrected detection time is calculated for each Hb type.

[0177] Correction detection time = PkTimeRt + {TlAbs / (-average value of the slope of the approximate straight line)} ... Formula B

[0178] Figure 5 This is a diagram showing an example of the relationship between the type of Hb and the corrected detection time.

[0179] according to Figure 5 , determine the Hb type and the range of the correction detection time corresponding to the Hb type.

[0180] HbE: The corrected detection time is 1.010 or more and less than 1.070.

[0181] HbC: The corrected detection time is 1.070 or more and less than 1.110.

[0182] HbD: The corrected detection time is 1.110 or more and less than 1.145.

[0183] HbS: The corrected detection time is 1.145 or more and less than 1.190.

[0184] HbG: The corrected detection time is 1.190 or more and less than 1.250.

[0185] HbA: Corrected detection time is 1.250 or more and less than 1.450.

[0186] like Figure 5 Therefore, for the sample to be analyzed, the relative detection time PkTimeRt and the absorbance TlAbs are obtained, and the corrected detection time is calculated based on Formula B. Based on the corrected detection time, the type of Hb contained in the sample can be determined.

[0187] The method of acquiring the relative detection time PkTimeRt and absorbance TlAbs for the sample to be analyzed (the sample containing unknown Hb species) is the same as the method of acquiring the relative detection time PkTimeRt and absorbance TlAbs for known Hb species with different concentrations.

[0188] (Method B)

[0189] In method B, the specific parameter is data of a boundary line separated by components obtained by plotting detection time and absorbance on a two-dimensional plane using known components.

[0190] In method B, the process of determining the components contained in the sample includes: using the boundary line data, the process of determining the area to which the acquired detection time and the acquired absorbance belong in each area separated by the boundary line; and the process of determining the components contained in the sample based on the determined area.

[0191] The specific parameters in method B are calculated, for example, by the following method.

[0192] Similar to method A, relative detection time PkTimeRt and absorbance TlAbs are obtained for known Hb species with different concentrations.

[0193] Figure 6 This is a graph in which the horizontal axis represents the relative detection time PkTimeRt and the vertical axis represents the absorbance TlAbs.

[0194] like Figure 6 As shown in FIG. 1 , the boundary lines separating each Hb type are drawn, and the linear equation of the boundary lines is calculated.

[0195] The E line is the boundary separating HbE and HbC.

[0196] The C line is the boundary separating HbC from HbD.

[0197] Line D is the boundary separating HbD and HbS.

[0198] The S line is the boundary line separating HbS and HbG.

[0199] The G line is the boundary separating HbG from HbA.

[0200] The linear equation of each boundary line is set as follows, for example.

[0201] E line: TlAbs = 4583-4250 × PkTimeRt

[0202] Line C: TlAbs = 4450-4000 × PkTimeRt

[0203] D line: TlAbs = 4550-3950 × PkTimeRt

[0204] S line: TlAbs = 4794-3967 × PkTimeRt

[0205] G line: TlAbs = 5079 - 3991 × PkTimeRt

[0206] like Figure 6 As shown, Hb types are separated by boundary lines. Therefore, for the sample to be analyzed, the relative detection time PkTimeRt and the absorbance TlAbs are obtained, and in each area separated by the boundary line, the area to which the obtained relative detection time and the obtained absorbance belong is determined. Based on the determined area, the Hb type contained in the sample can be determined.

[0207] When the following formulas E1 and E2 are satisfied, it is determined to be HbE.

[0208] PkTimeRt>1…Formula E1

[0209] TlAbs<4583-4250×PkTimeRt…Formula E2

[0210] When the following formula C1 is satisfied, it is determined to be HbC.

[0211] 4583-4250×PkTimeRt≤TlAbs<4450-4000×PkTimeRt…Formula C1

[0212] When the following formula D1 is satisfied, it is determined to be HbD.

[0213] 4450-4000×PkTimeRt≤TlAbs<4550-3950×PkTimeRt…Formula D1

[0214] When the following formula S1 is satisfied, it is determined to be HbS.

[0215] 4550-3950×PkTimeRt≤TlAbs<4794-3967×PkTimeRt…Formula S1

[0216] When the following formula G1 is satisfied, it is determined to be HbG.

[0217] 4794-3967×PkTimeRt≤TlAbs<5079-3991×PkTimeRt…Formula G1

[0218] When the following formula A1 is satisfied, it is determined to be HbA.

[0219] 5079-3991×PkTimeRt≤TlAbs…Formula A1

[0220] [Sample analysis device]

[0221] The sample analysis device involved in the present disclosure includes: means for separating multiple components contained in a sample by capillary electrophoresis; means for obtaining an electrophoretogram of the sample; means for obtaining the detection time of each peak and the concentration corresponding to each peak based on the electrophoretogram; and means for determining the components contained in the sample using parameters for the obtained detection time and the obtained concentration, wherein the parameter represents the correlation between the detection time and the concentration calculated using known components.

[0222] The means for obtaining the electrophoresis diagram of the sample preferably includes: a means for optically measuring the sample to obtain the absorbance; a means for obtaining the absorbance as an original waveform plotted on a two-dimensional plane along the time axis; and a means for obtaining a time-differentiated waveform, which is a waveform obtained by differentiating the original waveform along the time axis.

[0223] The means for acquiring the detection time of each peak and the concentration corresponding to each peak based on the electropherogram preferably includes: acquiring the detection time of each peak in the time-differential waveform, and acquiring the absorbance corresponding to the acquired detection time of each peak.

[0224] The means for determining the components contained in the sample preferably includes the step of determining the components contained in the sample using a parameter representing a correlation between the detection time and the absorbance calculated using known components, for the acquired detection time and the acquired concentration.

[0225] Specifically, the parameter representing the correlation between detection time and concentration is data of the slope of an approximate straight line according to the components obtained by plotting the detection time and absorbance on a two-dimensional plane using known components; the process of determining the components contained in the sample preferably includes: using the slope data, correcting the acquired detection time, and calculating the corrected detection time; and determining the components contained in the sample based on the corrected detection time.

[0226] In addition, the parameters representing the correlation between detection time and concentration are data of boundary lines separated by components, which are obtained by plotting detection time and absorbance on a two-dimensional plane using known components; the means for determining the components contained in the sample preferably include: using the boundary line data, in each area separated by the boundary line, a means for determining the area to which the acquired detection time and the acquired absorbance belong; and a means for determining the components contained in the sample based on the determined area.

[0227] <Sample Analysis System>

[0228] Figure 7 The schematic configuration of a sample analysis system A1 that can be used to execute the sample analysis method of the present embodiment is shown. The sample analysis system A1 is configured to include a sample analysis device 100 and an analysis chip 10. The sample analysis system A1 is a system that executes an analysis method based on capillary electrophoresis on a sample Sa.

[0229] The analysis chip 10 holds the sample Sa and provides a place for analyzing the sample Sa when loaded in the sample analysis device 100. Figure 8 and Fig. 9 As shown, the analysis chip 10 includes a main body 21 , a mixing tank 22 , an introduction tank 23 , a filter 24 , a discharge tank 25 , an electrode tank 26 , a flow channel 27 , and a communication flow channel 28 . Figure 8 is a top view of the analysis chip 10, Fig. 9 It is along Figure 8The analysis chip 10 is not limited to a disposable type, and can also be used for multiple analyses. In addition, the sample analysis system of this embodiment is not limited to a structure having a separate analysis chip 10 loaded in the sample analysis device 100, but can also be a structure in which a functional part that performs the same function as the analysis chip 10 is assembled in the sample analysis device 100.

[0230] The main body 21 is the base of the analysis chip 10. The material of the main body 21 is as described above for the material of the capillary channel. Fig. 9 The upper part 2A and the lower part 2B are formed separately and connected to each other. In addition, the present invention is not limited to this, and the main body 21 may be formed integrally, for example.

[0231] The mixing tank 22 is a portion where the sample Sa and the diluent Ld are mixed. The mixing tank 22 is formed as a recessed portion that opens upward, for example, by a through hole formed in the upper portion 2A of the main body 21. The introduction tank 23 is a tank for introducing a sample solution into the mixing tank 22, the sample solution being a solution obtained by mixing the sample Sa and the diluent Ld. The introduction tank 23 is formed as a recessed portion that opens upward, for example, by a through hole formed in the upper portion 2A of the main body 21.

[0232] The filter 24 is provided at the opening of the introduction tank 23, which is an example of an introduction path to the introduction tank 23. The specific structure of the filter 24 is not limited, and a preferred example is a cellulose acetate membrane filter (manufactured by ADVANTEC, pore size 0.45 μm).

[0233] The discharge groove 25 is a groove located on the downstream side of the flow path 27. The discharge groove 25 is formed as a recessed portion opened upward by, for example, a through hole formed in the upper part 2A of the main body 21. The electrode groove 26 is a groove into which the electrode 31 is inserted in the capillary electrophoresis method. The electrode groove 26 is formed as a recessed portion opened upward by, for example, a through hole formed in the upper part 2A of the main body 21. The communication flow path 28 connects the introduction groove 23 and the electrode groove 26, and constitutes a conduction path between the introduction groove 23 and the electrode groove 26.

[0234] The flow path 27 is formed as a capillary connecting the introduction groove 23 and the discharge groove 25, and is a place where the electro-osmotic flow (EOF) in the electrophoresis method is generated. The flow path 27 is, for example, a groove formed in the lower part 2B of the main body 21. In addition, a recessed portion for promoting the irradiation of light to the flow path 27 and the emission of light through the flow path 27 can also be appropriately formed in the main body 21. The cross-sectional shape and size of the flow path 27 (the flow path height and flow path width in the case of a rectangular shape, and the inner diameter and flow path length in the case of a circular shape) are as described in the cross-sectional shape and size of the capillary flow path. The overall size of the analysis chip 10 is appropriately set according to the size of the flow path 27 and the size, configuration, etc. of the mixing groove 22, the introduction groove 23, the discharge groove 25 and the electrode groove 26.

[0235] The analysis chip 10 having the above-described structure is an example, and an analysis chip having a structure capable of performing component analysis by capillary electrophoresis can be appropriately adopted.

[0236] The sample analyzer 100 performs analysis processing on the sample Sa in a state where the analysis chip 10 on which the sample Sa is spotted is loaded. The sample analyzer 100 includes an electrode 31, an electrode 32, a light source 41, an optical filter 42, a lens 43, a slit 44, a detector 45, a dispenser 6, a pump 61, a diluent tank 71, a phoresis tank 72, and a control unit 8. The light source 41, the optical filter 42, the lens 43, and the detector 45 constitute the measuring unit 40 in this embodiment.

[0237] The electrodes 31 and 32 are used to apply a predetermined voltage to the flow channel 27 in the capillary electrophoresis method. The electrode 31 is inserted into the electrode groove 26 of the analysis chip 10, and the electrode 32 is inserted into the discharge groove 25 of the analysis chip 10. The voltage applied to the electrodes 31 and 32 is as described in the voltage applied to both ends of the capillary flow channel.

[0238] The light source 41 is a part that emits light for measuring absorbance as an optical measurement value in capillary electrophoresis. The light source 41 is, for example, a LED (Light-emitting Diode) chip that emits light of a predetermined wavelength band. The optical filter 42 attenuates light of a predetermined wavelength in the light from the light source 41 and transmits light of the remaining wavelengths. The lens 43 is used to focus the light that has passed through the optical filter 42 toward the analysis part of the flow path 27 of the analysis chip 10. The slit 44 is used to remove excess light that may cause scattering, etc. in the light focused by the lens 43.

[0239] The detector 45 receives light from the light source 41 that has passed through the flow channel 27 of the analysis chip 10 , and is configured to include, for example, a photodiode, a photo IC (Integrated Circuit), or the like.

[0240] Thus, the path of the light emitted from the light source 41 to the detector 45 is the optical path. Then, the optical measurement value is measured for the solution (i.e., either the sample solution or the electrophoretic solution or a mixed solution thereof) flowing in the flow path 27 at the position where the optical path intersects the flow path 27, i.e., the measurement position 27A. That is, at the measurement position 27A of the flow path 27, the measurement unit 40 measures the optical measurement value of the sample solution. As the optical measurement value, for example, absorbance can be cited. The absorbance indicates the degree to which the light of the optical path is absorbed by the solution flowing in the flow path 27, and indicates the absolute value of the common logarithm of the ratio of the incident light intensity to the transmitted light intensity. In this case, a general-purpose spectrophotometer can be used as the detector 45. In addition, even if the absorbance is not used, an optical measurement value such as the value of the transmitted light intensity itself can be simply used. The following is an example of using absorbance as an optical measurement value.

[0241] The dispenser 6 dispenses the desired amount of diluent Ld, electrophoretic liquid Lm and sample solution, and includes, for example, a nozzle. The dispenser 6 can be freely moved at a plurality of predetermined positions in the sample analysis device 100 by a driving mechanism not shown in the figure. The pump 61 is a suction source and a discharge source for the dispenser 6. In addition, the pump 61 can also be used as a suction source and a discharge source for ports not shown in the figure provided in the sample analysis device 100. These ports are used for filling the electrophoretic liquid Lm, etc. In addition, a dedicated pump different from the pump 61 can also be provided.

[0242] The diluent tank 71 is a tank for storing the diluent Ld. The diluent tank 71 may be a tank permanently provided in the sample analysis device 100, or a tank in which a container enclosed with a predetermined amount of the diluent Ld is loaded in the sample analysis device 100. The moving liquid tank 72 is a tank for storing the moving liquid Lm. The moving liquid tank 72 may be a tank permanently provided in the sample analysis device 100, or a tank in which a container enclosed with a predetermined amount of the moving liquid Lm is loaded in the sample analysis device 100.

[0243] The diluent Ld is used to generate a sample solution by mixing with the sample Sa. The main agent of the diluent Ld is not particularly limited, and water and physiological saline can be cited. As a preferred example, a liquid with a composition similar to that of the electrophoresis liquid Lm described later can be cited. In addition to the above-mentioned main agent, the diluent Ld can also be added with additives as needed.

[0244] The electrophoresis liquid Lm is a medium that is filled into the discharge tank 25 and the flow path 27 in the analysis process based on the electrophoresis method and generates the electroosmotic flow in the electrophoresis method. The preferred embodiment of the electrophoresis liquid Lm is as described above. In addition, in the electrophoresis liquid Lm, additives can also be added as needed, as described in the description of the diluent Ld.

[0245] The control unit 8 controls each unit in the sample analysis device 100. Fig.10 As shown in the hardware structure of FIG. 8 , the control unit 8 includes a CPU (Central Processing Unit) 81, a ROM (Read Only Memory) 82, a RAM (Random Access Memory) 83, and a memory 84. Each structure is connected via a bus 89 so as to be able to communicate with each other.

[0246] The CPU 81 is a central processing unit that executes various programs or controls various components. That is, the CPU 81 reads programs from the ROM 82 or the memory 84 and executes the programs using the RAM 83 as a work area. The CPU 81 controls the above-mentioned components and performs various calculations according to the programs recorded in the ROM 82 or the memory 84.

[0247] ROM 82 stores various programs and various data. RAM 83 temporarily stores programs or data as a work area. Memory 84 is composed of HDD (Hard Disk Drive), SSD (Solid State Drive) or flash memory, and stores various programs including operating systems and various data. In this embodiment, programs and various data for executing the sample analysis method of this embodiment are stored in ROM 82 or memory 84.

[0248] When executing the sample analysis method of this embodiment, the sample analysis device 100 performs measurement and analysis using the above-described hardware resources and each of the above-described configurations.

[0249] [Example]

[0250] Hereinafter, examples will be described, but the present invention is not limited to these examples. In the following description, "parts" and "%" are based on mass unless otherwise specified.

[0251] <Separation Device and Measurement Equipment>

[0252] As a separation device, use Figure 1A resin chip of the capillary flow path 1 with the shown structure (flow path width: 40 μm, flow path height: 40 μm, flow path length: 30 mm, distance (x) from the sample holding tank 2 to the detection unit 4: 20 mm). The capacities of the sample holding tank 2 and the running buffer holding tank 3 are 10 μL. The inner wall of the capillary flow path is coated with poly(diallyldimethylammonium chloride).

[0253] The separation device is The Lab 001A1c HD (Arkray, Inc.), and the measuring device is The Lab 001 (Arkray, Inc.).

[0254] <Preparation of Capillary Electrophoresis Solution>

[0255] Mix the following substances, and add sodium hydroxide and water until the pH becomes 9.8 to prepare the capillary electrophoresis solution.

[0256] · Dimethylamine-ammonia-epichlorohydrin condensate (cationic polymer, manufactured by SENKA, UNISENSE KHE 1000L, weight-average molecular weight: 100,000 - 500,000)…1.5% by mass

[0257] · Sodium azide…0.02% by mass

[0258] · Sodium hydroxide

[0259] · Water

[0260] <Preparation of Dilution Solution>

[0261] Mix the following substances, and add hydrochloric acid and water until the pH becomes 8.8 to prepare the capillary dilution solution.

[0262] · Polyethyleneimine (manufactured by Fujifilm Wako Pure Chemical Corporation, weight-average molecular weight: 70,000)…1% by mass

[0263] · EMULGEN LS-110 (manufactured by Kao Corporation)…0.4% by mass

[0264] · Sodium azide…0.02% by mass

[0265] · Sucrose…7.87% by mass

[0266] · Sodium chloride…0.26% by mass

[0267] · Hydrochloric acid

[0268] · Water

[0269] <Preparation of Hb Specimen>

[0270] Both normal human whole blood and various mutant Hb carrier whole blood contain HbA2.

[0271] Normal whole blood: AA (HbA / HbA)

[0272] · Whole blood of various mutant Hb carriers: AE (HbA / HbE), AC (HbA / HbC), AD (HbA / HbD), AS (HbA / HbS), AG (HbA / HbG), CC (HbC / HbC), DD (HbD / HbD), SS (HbS / HbS)

[0273] [Example 1]

[0274] (Specific parameter settings)

[0275] -Separation process-

[0276] 9 μL of the capillary electrophoresis solution was supplied to the moving solution holding reservoir 3 in the capillary electrophoresis chip, and the capillary channel 1 was filled with the capillary electrophoresis solution by capillary phenomenon.

[0277] 9 μL of samples of normal human whole blood and various mutant Hb carrier whole blood diluted 41 times or 121 times with a diluting solution were supplied to the sample holding reservoir 2 .

[0278] Next, the negative electrode was brought into contact with the sample holding reservoir 2 and the positive electrode was brought into contact with the moving solution holding reservoir 3, and a voltage was applied under constant current control of 75 μA to start electrophoresis. The electrophoresis was performed for 90 seconds.

[0279] - Electropherogram acquisition process -

[0280] During the electrophoresis, the detection unit 4 is irradiated with light of 415 nm, and its absorbance is measured to obtain an original waveform A of the absorbance spectrum.

[0281] The original waveform A is differentiated along the time axis to obtain a time-differentiated waveform A.

[0282] The Lab 001 manufactured by ARKRAY was used for light irradiation, absorbance measurement, and electrophoresis acquisition.

[0283] The above-mentioned measurement was performed on normal whole blood and whole blood of various mutant Hb carriers to obtain electrophoresis patterns. The capillary electrophoresis chip was used once for each measurement.

[0284] -Detection time / concentration acquisition steps-

[0285] According to the time differential waveform A, obtain PkTime, EOFTime, PkTlTime and A2Time.

[0286] Based on the following formula A, PkTime is converted into the relative detection time PkTimeRt.

[0287] PkTimeRt=(PkTime-EOFTime) / (A2Time-EOFTime)…Formula A

[0288] In addition, based on the original waveform A, the absorbance TlAbs corresponding to PkTlTime is obtained.

[0289] The horizontal axis is the relative detection time PkTimeRt, and the vertical axis is the absorbance TlAbs. Figure 4 In the above example, approximate straight lines were drawn for each type of Hb, and the slopes of the approximate straight lines were calculated. The average value of the slopes of the approximate straight lines was -4923.

[0290] Based on the following formula B, the corrected detection time is calculated.

[0291] Correction detection time = PkTimeRt + {TlAbs / (-average value of the slope of the approximate straight line)} ... Formula B

[0292] according to Figure 5 , determines the Hb type and the range of the correction detection time corresponding to the Hb type.

[0293] HbE: The corrected detection time is 1.010 or more and less than 1.070.

[0294] HbC: The corrected detection time is 1.070 or more and less than 1.110.

[0295] HbD: The corrected detection time is 1.110 or more and less than 1.145.

[0296] HbS: The corrected detection time is 1.145 or more and less than 1.190.

[0297] -HbG: The corrected detection time is 1.190 or more and less than 1.250.

[0298] HbA: Corrected detection time is 1.250 or more and less than 1.450.

[0299] (Component determination process)

[0300] By determining which of the above-mentioned ranges of corrected detection time the obtained corrected detection time falls within, the type of Hb can be identified.

[0301] [Example 2]

[0302] Separation was performed by the same method as in the case where the normal human whole blood and the various mutant Hb carrier whole blood were used in the sample holding chamber 2, and an electrophoresis pattern was obtained.

[0303] According to the electrophoresis diagram, the relative detection time PkTimeRt and absorbance TlAbs were obtained.

[0304] Figure 6 This is a graph in which the horizontal axis represents the relative detection time PkTimeRt and the vertical axis represents the absorbance TlAbs.

[0305] like Figure 6 As shown in FIG. 1 , the boundary lines separating each Hb type are drawn, and the linear equation of the boundary lines is calculated.

[0306] The linear equation of each boundary line is set as follows.

[0307] E line: TlAbs = 4583-4250 × PkTimeRt

[0308] Line C: TlAbs = 4450-4000 × PkTimeRt

[0309] D line: TlAbs = 4550-3950 × PkTimeRt

[0310] S line: TlAbs = 4794-3967 × PkTimeRt

[0311] G line: TlAbs = 5079 - 3991 × PkTimeRt

[0312] (Component determination process)

[0313] The region to which the obtained relative detection time PkTimeRt and absorbance TlAbs belong is determined, and the type of Hb can be determined based on the determined region.

[0314] [Comparative Example 1]

[0315] Similar to Example 1, normal human whole blood and various mutant Hb carrier whole blood were used to obtain the relative detection time PkTimeRt.

[0316] Fig.11 It is a graph showing the relationship between Hb types and relative detection time.

[0317] like Fig.11 As shown in FIG. 1 , there is an overlapped portion of the relative detection time PkTimeRt for each Hb type. That is, it is known that the components contained in the sample cannot be determined only by the relative detection time PkTimeRt.

[0318] Explanation of symbols

[0319] 1: Capillary flow path;

[0320] 2: Sample holding tank;

[0321] 3: swimming liquid holding tank;

[0322] 4: Detection department;

[0323] Tx: detection time of peak X;

[0324] Ta2: detection time of HbA2 peak;

[0325] Ty: detection time of Y peak;

[0326] A1: Analysis system;

[0327] Sa: specimen;

[0328] Ld: diluent;

[0329] Lm: swimming liquid;

[0330] 100: component analysis device;

[0331] 10: Analyze the chip;

[0332] 2A: upper part;

[0333] 2B: lower part;

[0334] 21: Subject;

[0335] 22: Mixing tank;

[0336] 23: import slot;

[0337] 24: Filter;

[0338] 25: discharge trough;

[0339] 26: electrode slot;

[0340] 27: Flow path;

[0341] 27A: Determination of position;

[0342] 28: communication flow path;

[0343] 31: electrode;

[0344] 32: Electrode;

[0345] 40: measurement unit;

[0346] 41: light source;

[0347] 42: optical filter;

[0348] 43: Lens;

[0349] 44: Slit;

[0350] 45: detector;

[0351] 6: Dispenser;

[0352] 61: Pump;

[0353] 71: dilution tank;

[0354] 72: swimming tank;

[0355] 8: Control department;

[0356] 81: CPU;

[0357] 82: ROM;

[0358] 83: RAM;

[0359] 84: memory;

[0360] 89: Bus.

Claims

1. A sample analysis method comprising: A process of separating multiple components contained in a sample by capillary electrophoresis; A step of obtaining an electrophoretic pattern of the sample; A step of obtaining the detection time of each peak and the concentration corresponding to each peak according to the electrophoresis diagram; as well as A step of determining a component contained in the sample using a parameter for the acquired detection time and the acquired concentration, wherein the parameter represents a correlation between the detection time and the concentration calculated using known components.

2. The sample analysis method according to claim 1, wherein: The process of obtaining the electrophoresis pattern of the sample comprises: A step of optically measuring the sample to obtain absorbance; A step of obtaining the absorbance as an original waveform plotted on a two-dimensional plane along a time axis; and a step of acquiring a time-differentiated waveform, wherein the time-differentiated waveform is a waveform obtained by differentiating the original waveform along the time axis, According to the electrophoresis diagram, the process of obtaining the detection time of each peak and the concentration corresponding to each peak includes: Acquire the detection time of each peak in the time differential waveform, and acquire the absorbance corresponding to the acquired detection time of each peak, The process of determining the components contained in the sample comprises: A step of determining a component contained in the sample using a parameter for the acquired detection time and the acquired absorbance, wherein the parameter represents a correlation between the detection time and the absorbance calculated using a known component.

3. The sample analysis method according to claim 1, wherein: The parameter indicating the correlation between the detection time and the concentration is a parameter obtained by plotting the detection time and the absorbance on a two-dimensional plane using a known component.

4. The sample analysis method according to claim 3, wherein: The parameter representing the correlation between the detection time and the concentration is data of the slope of an approximate straight line for each component obtained by plotting the detection time and absorbance on a two-dimensional plane using known components. The process of determining the components contained in the sample comprises: The step of correcting the acquired detection time using the slope data to calculate the corrected detection time; and A step of specifying a component contained in the sample based on the corrected detection time.

5. The sample analysis method according to claim 3, wherein: The parameter representing the correlation between the detection time and the concentration is data of a boundary line separated by component obtained by plotting the detection time and absorbance on a two-dimensional plane using known components. The process of determining the components contained in the sample comprises: using the data of the boundary line, determining, in each area separated by the boundary line, an area to which the acquired detection time and the acquired absorbance belong; and A step of determining components contained in the sample based on the determined region.

6. The sample analysis method according to claim 1, wherein: The component is hemoglobin.

7. A sample analysis device comprising: A method of separating multiple components contained in a sample by capillary electrophoresis; means for obtaining an electrophoretic pattern of the sample; According to the electrophoresis diagram, a means of obtaining the detection time of each peak and the concentration corresponding to each peak; as well as Means for determining a component contained in the sample using a parameter for the acquired detection time and the acquired concentration, wherein the parameter represents a correlation between the detection time and the concentration calculated using known components.

Citation Information

Patent Citations

  • Method for analyzing sample, and solution used therefor

    JP2016136135A